TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OPT

Opthea Ltd

Healthcare · Biotechnology

3.40$ +7.2% vs. previous close Closing price · As of: Jul 2, 2026

Statements

Income Statement

Opthea Ltd (OPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 25), "Revenue" came in at 0.0 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement OPT
Line item Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q1 25
– 0.3 – 0.3 – 0.3 – 0.0 – 0.0 – 0.0 – 0.0 – 0.0 – 0.0 – 0.1 – 0.3 – -0.1 – 0.0 -0.1 -0.2 -0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0
– 0.1 – 0.2 – 0.3 – 0.1 – 0.1 – 0.1 – 0.1 – 0.1 – 0.1 – 0.1 – 0.2 – 0.3 – 0.1 0.2 0.5 0.2 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0
– 0.1 – 0.1 – 0.0 – 0.0 – -0.1 – -0.1 – -0.1 – 0.0 – 0.0 – 0.0 – 0.1 – -0.4 – 0.0 -0.3 -0.7 -0.3 0.1 -0.1 -0.1 0.1 0.0 0.1 0.0 0.0 -0.1 – 0.0
0.9 3.9 1.4 3.3 1.4 1.9 0.9 3.9 0.9 3.7 1.2 2.5 1.2 11 6.2 14 6.2 17 7.8 14 7.8 8.3 4.5 9.1 4.5 19 8.0 16 8.1 43 31 68 48 92 45 90 130 139 69 1.8
0.4 1.4 0.6 1.9 0.6 1.5 0.7 2.5 0.7 2.2 0.7 2.4 0.7 2.6 0.8 1.0 0.8 1.0 1.2 1.5 1.2 2.4 1.0 4.2 1.0 2.6 6.3 13 6.4 3.6 8.4 18 11 25 9.8 20 13 9.8 – 1.8
1.4 5.4 2.1 5.2 2.1 3.5 1.7 6.5 1.7 6.0 2.1 4.9 2.1 13 -7.5 16 -7.5 20 9.1 17 9.1 12 -6.4 13 -6.4 26 14 27 15 54 39 85 60 118 46 106 144 287 85 4.4
-1.9 -5.2 -2.3 -5.1 -2.3 -3.4 -2.0 -6.5 -2.0 -6.1 -2.5 -5.0 -2.5 -13 -7.5 -16 -7.5 -20 -9.2 -17 -9.2 -12 -6.4 -13 -6.4 -26 -14 -27 -14 -54 -38 -83 -62 -118 -53 -106 -144 -288 -85 -4.1
– – – – – – – – – – – – – – – – – – – – – – – 0.1 – – – – – – – 0.1 – 5.2 – 15 16 30 22 0.0
-1.7 -4.3 -2.0 -3.8 -2.0 -2.6 -2.0 -5.5 -2.0 -5.0 -2.3 -4.4 -2.3 -13 -7.2 -16 -7.2 -19 -8.9 -17 -8.9 -11 -6.3 -13 -6.3 -39 -14 -29 -15 -56 -39 -85 -62 -118 -52 -103 -155 -193 -137 -3.7
-0.7 1.3 -0.7 -1.4 -0.7 -0.9 -0.4 -0.7 -0.4 -2.7 -0.8 -0.5 -0.8 -1.9 -3.0 -10 -3.0 -7.6 -3.7 -7.0 -3.7 3.8 -2.1 4.4 -2.1 -3.5 1.6 3.2 1.6 -4.0 2.3 4.9 1.6 -3.1 2.9 -5.7 -7.7 -6.6 -6.0 -1.2
-1.0 -2.9 -1.3 -2.4 -1.3 -1.7 -1.6 -4.8 -1.6 -2.3 -1.5 -3.9 -1.5 -11 -4.2 -5.5 -4.2 -11 -5.2 -9.6 -5.2 -7.6 -4.1 -8.5 -4.1 -35 -13 -26 -13 -52 -37 -80 -60 -115 -49 -97 -147 -186 -131 -2.5
-1.7 -4.6 -2.0 -4.2 -2.0 -2.7 -2.0 -5.0 -2.0 -5.1 -2.3 -4.7 -2.3 -13 -7.2 -16 -7.2 -20 -8.9 -17 -8.9 -12 -6.2 -13 -6.2 -26 -14 -27 -14 -54 -38 -83 -62 -113 -53 -106 -139 -147 -115 -4.5

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?